The limits of “ordre public” and “morality” for the patentability of human embryonic stem cell inventions
Author | Viola Prifti |
DOI | http://doi.org/10.1111/jwip.12109 |
Published date | 01 March 2019 |
Date | 01 March 2019 |
P
2wileyonlinelibrary.com/journal/jwip J World Intellect Prop. 2019;22:2–15.
DOI: 10.1111/jwip.12109
ORIGINAL ARTICLE
The limits of “ordre public”and “morality”for
the patentability of human embryonic stem
cell inventions
Viola Prifti
Rights & Science, Jean Monnet Centre of
Excellence, University of Perugia, Perugia,
Italy
Correspondence
Viola Prifti, Rights & Science, Jean Monnet
Centre of Excellence, University of Perugia,
Piazzale Gambuli, Building A-7th floor,
Perugia, Italy.
Email: viola.prifti@gmail.com
Inventions involving huma n embryonic stem cells (hESC )
have unprecedented potential to improve human life
through discovery of new d rugs and treatment of
incurable neurodegenerative diseases, but at the same
time, the use of human embryos in research gives rise to
contrasting ethical, mor al and religious views on the
patentability of such inventio ns. Whether and to what
extent patent offices should take these views into account
is an open question. The “ordre public”and “morality ”
clause in patent law may help u s find an answer, but
neither the legislator nor cour ts have clarified the meaning
of these vague terms. Judicial interpretation has some-
times increased their ambiguity and raised legal uncer-
tainty for the patentabilit y of hESC inventions. This
situation may be desirable in some cases, but not in
others where the principle s of the legal system as a whole
come into play. This paper will shed light on the meaning
of “ordre public”and “morality”for hESC inventions by
examining patent law in the broader legal framework and
emphasizing the intercon nectedness of national lega l
systems in a global market as well as the common interest
in healthcare innovations .
KEYWORDS
hESC inventions, ordre public and morality, patent law
© 2018 The Authors. The Journal of World Intellectual Property © 2018 John Wiley & Sons Ltd
1
W
c
s
f
v
e
t
t
v
c
i
T
t
(
l
o
d
2
T
c
t
d
e
e
A
(
T
s
i
p
T
t
T
o
m
r
t
To continue reading
Request your trial